 |
|
NBGI backs heart disease specialist
London-based investor NBGI Ventures has led a $5 million (£3 million) Series B investment round into Advanced Cardiac Therapeutics (ACT).
US-based ACT, a developer of systems to treat sufferers of irregular heart rhythms, will use the proceeds to fund commercialisation of its technology in Europe where it is working with German catheter development partner Contract Medical International.
Peter van der Sluis, ACT’s chief executive, says, ‘The completion of our B round funding allows us to fully prepare for the commercial launch of ACT’s technology in 2010.’
Founded in 2007, ACT’s technology involves advancing a catheter into the heart in order to prevent the spread of electrical signals that cause arrhythmia. The process is known as cardiac catheter ablation.
NBGI manages funds of more than €100 million (£90 million) and specialises in medical technology investments in Europe and the US.
People also read ... |
Related Articles |
Interesting links
Other Sector Watch
- CFOs expect rise in M&A Jul 26 2010
- Takeovers to entertain
Jun 03 2010 - Economic review
May 18 2010 - Small-caps on the up May 11 2010
- A Numbers Game
May 05 2010
M&A News
- Salamanca Capital buys Barcelona marina Jul 30 2010
- KBC Peel Hunt in £74 million buy-out Jul 29 2010
- Meridian Bioscience acquires Bioline Jul 28 2010
- Desmond scoops Channel Five for £104 million Jul 27 2010
- Graphite backs Teaching Personnel MBO Jul 26 2010
Special Offers
M&A Deals
- Palamon sells Australian Retail Decisions Jul 30 2010
- Thermal Engineering bought by Privet Capital Jul 30 2010
- Aegis to acquire Mitchell Communication Group Jul 29 2010
- IDOX to buy CEMS Jul 27 2010
- MobileWave reverses onto AIM Jul 26 2010